美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Zura Bio

1.50

+0.10007.14%

盤後：1.47-0.0290-1.93%19:51 EDT

成交量：47.11萬

成交額：67.95萬

市值：9,281.25萬

市盈率：-2.09

高：1.52

開：1.37

低：1.35

收：1.40

資料載入中...

總覽公司新聞公告

Zura Bio Limited盤中異動下午盤股價大漲5.00%

Zura Bio Limited盤中異動股價大跌5.43%報1.53美元

Zura Bio Limited盤中異動股價大漲5.37%報1.77美元

Zura Bio Limited盤中異動早盤股價大跌5.23%報1.81美元

Zura Bio Limited7月18日成交額為747.32萬美元

Zura Bio Limited盤中異動早盤股價大漲5.43%

Zura Bio Limited盤中異動股價大跌5.04%報1.32美元

Zura Bio Limited盤中異動早盤股價大漲5.13%

Zura Bio Limited盤中異動下午盤股價大漲5.00%報1.16美元

Zura Bio Limited盤中異動早盤股價大漲5.31%報1.19美元

Zura Bio Limited盤中異動股價大漲5.24%

Zura Bio Limited盤中異動早盤快速上漲7.62%

Zura Bio Limited盤中異動下午盤股價大跌5.22%

Zura Bio Limited盤中異動早盤快速下跌5.08%報1.12美元

Zura Bio Limited盤中異動快速上漲5.36%報1.18美元

Zura Bio Limited盤中異動股價大跌5.00%

Zura Bio Limited盤中異動早盤股價大漲5.60%

Zura Bio Limited盤中異動快速上漲5.58%

Zura Bio Limited盤中異動早盤股價大漲5.45%報1.07美元

Zura Bio Limited盤中異動早盤急速拉昇6.28%報1.060美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ZURA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":1.5,"timestamp":1754078400000,"preClose":1.4,"halted":0,"volume":471119,"hourTrading":{"tag":"盘后","latestPrice":1.471,"preClose":1.5,"latestTime":"19:51 EDT","volume":573,"amount":846.43,"timestamp":1754092260637},"delay":0,"floatShares":24675037,"shares":61874998,"eps":-0.717206,"marketStatus":"休市中","change":0.1,"latestTime":"08-01 16:00:00 EDT","open":1.37,"high":1.515,"low":1.345,"amount":679529.2311632,"amplitude":0.121429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.717206,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.4,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.4,"latestTime":"09:25 EDT","volume":410,"amount":564.1199839999999,"timestamp":1754054713260},"postHourTrading":{"tag":"盘后","latestPrice":1.471,"preClose":1.5,"latestTime":"19:51 EDT","volume":573,"amount":846.43,"timestamp":1754092260637},"volumeRatio":1.4147746431695074,"impliedVol":1.5783,"impliedVolPercentile":0.5455},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","floatShares":24675037,"roa":"-31.40%","roe":"-55.05%","lyrEps":-0.604576,"volumeRatio":1.4147746431695074,"shares":61874998,"dividePrice":0,"high":1.515,"amplitude":0.121429,"preClose":1.4,"low":1.345,"week52Low":0.97,"pbRate":"0.67","week52High":5.07,"institutionHeld":0,"latestPrice":1.5,"eps":-0.717206,"divideRate":0,"volume":471119,"delay":0,"ttmEps":-0.717206,"open":1.37,"prevYearClose":2.5,"prevWeekClose":1.64,"prevMonthClose":1.4,"prevQuarterClose":1.05,"fiveDayClose":1.64,"twentyDayClose":1.13,"sixtyDayClose":1.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZURA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2556927848","title":"Zura Bio Limited盤中異動 下午盤股價大漲5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556927848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556927848?lang=zh_tw&edition=fundamental","pubTime":"2025-08-02 01:11","pubTimestamp":1754068266,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日01时11分，Zura Bio Limited股票出现波动，股价急速拉升5.00%。截至发稿，该股报1.47美元/股，成交量20.0436万股，换手率0.32%，振幅8.57%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.24%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802011106972d5b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802011106972d5b55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2555052609","title":"Zura Bio Limited盤中異動 股價大跌5.43%報1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555052609?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 21:54","pubTimestamp":1753797286,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时54分，Zura Bio Limited股票出现波动，股价大幅跳水5.43%。截至发稿，该股报1.53美元/股，成交量5.4816万股，换手率0.09%，振幅4.81%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.08%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544697258e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544697258e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2553424541","title":"Zura Bio Limited盤中異動 股價大漲5.37%報1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553424541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553424541?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 21:32","pubTimestamp":1753277520,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日21时32分，Zura Bio Limited股票出现波动，股价大幅拉升5.37%。截至发稿，该股报1.77美元/股，成交量3.9245万股，换手率0.06%，振幅2.98%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.57%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213200a6bd82ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213200a6bd82ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2553408446","title":"Zura Bio Limited盤中異動 早盤股價大跌5.23%報1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553408446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553408446?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 22:33","pubTimestamp":1753108436,"startTime":"0","endTime":"0","summary":"北京时间2025年07月21日22时33分，Zura Bio Limited股票出现异动，股价快速下跌5.23%。截至发稿，该股报1.81美元/股，成交量27.4275万股，换手率0.44%，振幅8.66%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.18%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072122335797aee654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072122335797aee654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2552252419","title":"Zura Bio Limited7月18日成交額為747.32萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552252419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552252419?lang=zh_tw&edition=fundamental","pubTime":"2025-07-19 15:49","pubTimestamp":1752911354,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，Zura Bio Limited成交额为747.32万美元，成交额较昨日减少43.68%，当日成交量为370.33万股。Zura Bio Limited于2025年7月18日跌2.55%，报1.91美元，该股过去5个交易日涨45.8%，年初至今跌23.6%，过去60日涨28.19%。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719154919a6b398e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719154919a6b398e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2552487611","title":"Zura Bio Limited盤中異動 早盤股價大漲5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552487611?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 22:09","pubTimestamp":1752761348,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时09分，Zura Bio Limited股票出现波动，股价大幅上涨5.43%。截至发稿，该股报1.36美元/股，成交量43.0438万股，换手率0.70%，振幅3.39%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.42%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220908a45150a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220908a45150a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2550968160","title":"Zura Bio Limited盤中異動 股價大跌5.04%報1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550968160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550968160?lang=zh_tw&edition=fundamental","pubTime":"2025-07-12 00:13","pubTimestamp":1752250398,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时13分，Zura Bio Limited股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量9.8682万股，换手率0.16%，振幅4.32%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.26%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001318a44539ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001318a44539ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2550625923","title":"Zura Bio Limited盤中異動 早盤股價大漲5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550625923?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 21:31","pubTimestamp":1752154277,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Zura Bio Limited股票出现波动，股价快速拉升5.13%。截至发稿，该股报1.42美元/股，成交量1.1955万股，换手率0.02%，振幅2.22%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.14%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213117a442b790&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213117a442b790&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2550527188","title":"Zura Bio Limited盤中異動 下午盤股價大漲5.00%報1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550527188?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 02:21","pubTimestamp":1751998909,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时21分，Zura Bio Limited股票出现波动，股价快速上涨5.00%。截至发稿，该股报1.16美元/股，成交量21.2763万股，换手率0.34%，振幅6.30%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.18%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709022149a69da3a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709022149a69da3a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2549530494","title":"Zura Bio Limited盤中異動 早盤股價大漲5.31%報1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549530494?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 21:32","pubTimestamp":1751895148,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时32分，Zura Bio Limited股票出现波动，股价快速拉升5.31%。截至发稿，该股报1.19美元/股，成交量2.8235万股，换手率0.05%，振幅0.00%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.09%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213228a43bf699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213228a43bf699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2548915816","title":"Zura Bio Limited盤中異動 股價大漲5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548915816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548915816?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 21:32","pubTimestamp":1751463175,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时32分，Zura Bio Limited股票出现异动，股价急速拉升5.24%。截至发稿，该股报1.11美元/股，成交量9926股，换手率0.02%，振幅3.81%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.22%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022132559533fd78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022132559533fd78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2547097035","title":"Zura Bio Limited盤中異動 早盤快速上漲7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547097035?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 21:31","pubTimestamp":1751290263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Zura Bio Limited股票出现波动，股价急速拉升7.62%。截至发稿，该股报1.13美元/股，成交量1.0915万股，换手率0.02%，振幅0.00%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.06%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213103a4c6c3da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213103a4c6c3da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2546264417","title":"Zura Bio Limited盤中異動 下午盤股價大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546264417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546264417?lang=zh_tw&edition=fundamental","pubTime":"2025-06-28 02:30","pubTimestamp":1751049015,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日02时30分，Zura Bio Limited股票出现波动，股价快速跳水5.22%。截至发稿，该股报1.09美元/股，成交量16.2412万股，换手率0.26%，振幅6.52%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.60%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628023015a4c1b8a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628023015a4c1b8a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2546308817","title":"Zura Bio Limited盤中異動 早盤快速下跌5.08%報1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546308817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546308817?lang=zh_tw&edition=fundamental","pubTime":"2025-06-26 23:02","pubTimestamp":1750950126,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时02分，Zura Bio Limited股票出现波动，股价大幅跳水5.08%。截至发稿，该股报1.12美元/股，成交量5.586万股，换手率0.09%，振幅6.33%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.20%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230206a71f1966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230206a71f1966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2545231994","title":"Zura Bio Limited盤中異動 快速上漲5.36%報1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545231994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545231994?lang=zh_tw&edition=fundamental","pubTime":"2025-06-24 23:11","pubTimestamp":1750777883,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时11分，Zura Bio Limited股票出现波动，股价大幅上涨5.36%。截至发稿，该股报1.18美元/股，成交量7.1059万股，换手率0.11%，振幅4.46%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.40%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231123a4bbb807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231123a4bbb807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2544422990","title":"Zura Bio Limited盤中異動 股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544422990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544422990?lang=zh_tw&edition=fundamental","pubTime":"2025-06-18 04:01","pubTimestamp":1750190469,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日04时01分，Zura Bio Limited股票出现波动，股价急速下挫5.00%。截至发稿，该股报1.14美元/股，成交量28.1265万股，换手率0.45%，振幅4.58%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为1.71%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618040109a70ef6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618040109a70ef6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2542343875","title":"Zura Bio Limited盤中異動 早盤股價大漲5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542343875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542343875?lang=zh_tw&edition=fundamental","pubTime":"2025-06-10 22:05","pubTimestamp":1749564328,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时05分，Zura Bio Limited股票出现波动，股价急速拉升5.60%。截至发稿，该股报1.32美元/股，成交量11.9111万股，换手率0.19%，振幅4.40%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.53%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220529a4a20fa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610220529a4a20fa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2540067833","title":"Zura Bio Limited盤中異動 快速上漲5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540067833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540067833?lang=zh_tw&edition=fundamental","pubTime":"2025-06-04 23:17","pubTimestamp":1749050277,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日23时17分，Zura Bio Limited股票出现波动，股价快速上涨5.58%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.70%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506042317589771a71d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506042317589771a71d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2540708865","title":"Zura Bio Limited盤中異動 早盤股價大漲5.45%報1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708865?lang=zh_tw&edition=fundamental","pubTime":"2025-06-03 22:34","pubTimestamp":1748961293,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时34分，Zura Bio Limited股票出现波动，股价快速拉升5.45%。截至发稿，该股报1.07美元/股，成交量12.5918万股，换手率0.20%，振幅6.67%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.12%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060322345497700536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060322345497700536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2539498261","title":"Zura Bio Limited盤中異動 早盤急速拉昇6.28%報1.060美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539498261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539498261?lang=zh_tw&edition=fundamental","pubTime":"2025-05-29 22:57","pubTimestamp":1748530666,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时57分，Zura Bio Limited股票出现异动，股价大幅拉升6.28%。截至发稿，该股报1.060美元/股，成交量15.0231万股，换手率0.24%，振幅4.01%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.76%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225746a49182c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529225746a49182c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZURA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"ZURA","fiscalQuarterEnding":"2025/03","expectedEps":-0.17,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-03-25","symbol":"ZURA","fiscalQuarterEnding":"2024/12","expectedEps":-0.17,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2024-11-07","symbol":"ZURA","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-08-13","symbol":"ZURA","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-05-09","symbol":"ZURA","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"盤前","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1730779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZURA","date":"2025-08-01","current":-1.394972,"percent":0.876271,"low":-19.645373,"twenty":-6.9051,"median":-3.454611,"eighty":-1.787565,"high":128.323671,"avg":-0.965522,"sd":19.015623,"marketCap":86624997},"quantilePoints":[{"date":"2023-03-17","current":6.722013,"twenty":3.077283,"median":4.444057,"eighty":5.810831,"marketCap":55244013},{"date":"2023-03-24","current":95.732999,"twenty":10.089418,"median":26.552728,"eighty":97.24286,"marketCap":786769586},{"date":"2023-03-31","current":115.825116,"twenty":24.157776,"median":96.676662,"eighty":121.414532,"marketCap":411078048},{"date":"2023-04-06","current":88.654345,"twenty":26.552728,"median":98.493858,"eighty":115.825116,"marketCap":314645530},{"date":"2023-04-14","current":87.334622,"twenty":54.797542,"median":97.620325,"eighty":115.825116,"marketCap":309961665},{"date":"2023-04-21","current":-9.744092,"twenty":23.559038,"median":92.924037,"eighty":110.2357,"marketCap":273592829},{"date":"2023-04-28","current":-7.850225,"twenty":-7.693221,"median":87.334622,"eighty":108.0657,"marketCap":220417184},{"date":"2023-05-05","current":-5.625705,"twenty":-7.58528,"median":65.049697,"eighty":103.1713,"marketCap":157957503},{"date":"2023-05-12","current":-8.54785,"twenty":-7.58528,"median":23.559038,"eighty":100.454223,"marketCap":240004959},{"date":"2023-05-19","current":-6.028363,"twenty":-7.236336,"median":-1.370145,"eighty":99.367392,"marketCap":169263255},{"date":"2023-05-26","current":-6.110447,"twenty":-6.948723,"median":-5.106395,"eighty":97.620325,"marketCap":171568003},{"date":"2023-06-02","current":-7.079022,"twenty":-6.974783,"median":-5.279277,"eighty":96.110464,"marketCap":198763468},{"date":"2023-06-09","current":-7.871872,"twenty":-7.497414,"median":-5.756178,"eighty":93.610039,"marketCap":221024977},{"date":"2023-06-16","current":-12.462533,"twenty":-7.876403,"median":-5.936326,"eighty":92.830881,"marketCap":349920722},{"date":"2023-06-23","current":-18.356145,"twenty":-8.029209,"median":-6.09739,"eighty":90.300117,"marketCap":515400472},{"date":"2023-06-30","current":-12.800188,"twenty":-8.465056,"median":-6.110447,"eighty":88.126456,"marketCap":359401332},{"date":"2023-07-07","current":-10.897043,"twenty":-9.736242,"median":-6.32748,"eighty":86.946468,"marketCap":305965163},{"date":"2023-07-14","current":-10.375213,"twenty":-10.301543,"median":-6.449998,"eighty":83.375453,"marketCap":291313310},{"date":"2023-07-21","current":-10.144993,"twenty":-10.16955,"median":-6.948723,"eighty":71.20099,"marketCap":284849257},{"date":"2023-07-28","current":-10.083602,"twenty":-10.362935,"median":-7.293596,"eighty":49.148579,"marketCap":283125510},{"date":"2023-08-04","current":-9.776643,"twenty":-10.464231,"median":-7.58528,"eighty":25.95399,"marketCap":274506773},{"date":"2023-08-11","current":-10.449013,"twenty":-10.439697,"median":-7.861048,"eighty":20.191633,"marketCap":293385452},{"date":"2023-08-18","current":-10.480065,"twenty":-10.545755,"median":-7.939831,"eighty":5.810831,"marketCap":294257326},{"date":"2023-08-25","current":-10.480065,"twenty":-10.559049,"median":-8.143707,"eighty":0.751603,"marketCap":294257326},{"date":"2023-09-01","current":-10.681903,"twenty":-10.607717,"median":-8.54785,"eighty":-4.921342,"marketCap":299924504},{"date":"2023-09-08","current":-4.570525,"twenty":-10.559388,"median":-8.166359,"eighty":-4.757501,"marketCap":287718274},{"date":"2023-09-15","current":-4.764426,"twenty":-10.559388,"median":-7.953905,"eighty":-4.66055,"marketCap":299924504},{"date":"2023-09-22","current":-4.258898,"twenty":-10.557695,"median":-7.871872,"eighty":-4.251973,"marketCap":268101119},{"date":"2023-09-29","current":-4.473574,"twenty":-10.542169,"median":-7.639251,"eighty":-4.258898,"marketCap":281615159},{"date":"2023-10-06","current":-4.757501,"twenty":-10.497996,"median":-7.350856,"eighty":-4.283136,"marketCap":299488567},{"date":"2023-10-13","current":-4.383549,"twenty":-10.495591,"median":-7.013872,"eighty":-4.383549,"marketCap":275947981},{"date":"2023-10-20","current":-3.573319,"twenty":-10.495591,"median":-6.455254,"eighty":-4.196573,"marketCap":224943378},{"date":"2023-10-27","current":-3.573319,"twenty":-10.490414,"median":-6.444741,"eighty":-4.161948,"marketCap":224943378},{"date":"2023-11-03","current":-3.414044,"twenty":-10.481615,"median":-6.238867,"eighty":-3.923726,"marketCap":214916832},{"date":"2023-11-10","current":-2.956991,"twenty":-10.480065,"median":-6.108894,"eighty":-3.419584,"marketCap":186145005},{"date":"2023-11-17","current":-2.648491,"twenty":-10.467644,"median":-5.982344,"eighty":-3.254768,"marketCap":185709068},{"date":"2023-11-24","current":-2.791485,"twenty":-10.449013,"median":-5.807949,"eighty":-3.105187,"marketCap":195735614},{"date":"2023-12-01","current":-3.015301,"twenty":-10.439697,"median":-5.625705,"eighty":-2.958376,"marketCap":211429338},{"date":"2023-12-08","current":-2.486846,"twenty":-10.40006,"median":-5.130482,"eighty":-2.892202,"marketCap":174374712},{"date":"2023-12-15","current":-2.611189,"twenty":-10.387491,"median":-4.906391,"eighty":-2.779051,"marketCap":183093447},{"date":"2023-12-22","current":-3.183163,"twenty":-10.362935,"median":-4.840601,"eighty":-2.781538,"marketCap":223199631},{"date":"2023-12-29","current":-2.984215,"twenty":-10.326099,"median":-4.826751,"eighty":-2.788998,"marketCap":209249654},{"date":"2024-01-05","current":-2.517932,"twenty":-10.262321,"median":-4.816363,"eighty":-2.775321,"marketCap":176554395},{"date":"2024-01-12","current":-2.443326,"twenty":-10.181318,"median":-4.764426,"eighty":-2.706932,"marketCap":171323154},{"date":"2024-01-19","current":-2.505498,"twenty":-10.172619,"median":-4.757501,"eighty":-2.649734,"marketCap":175682522},{"date":"2024-01-26","current":-2.238162,"twenty":-10.157271,"median":-4.695176,"eighty":-2.617406,"marketCap":156937240},{"date":"2024-02-02","current":-1.933523,"twenty":-10.132715,"median":-4.639775,"eighty":-2.529123,"marketCap":135576338},{"date":"2024-02-09","current":-2.437109,"twenty":-10.071324,"median":-4.573987,"eighty":-2.500524,"marketCap":170887217},{"date":"2024-02-16","current":-2.493063,"twenty":-10.01914,"median":-4.570525,"eighty":-2.486846,"marketCap":174810648},{"date":"2024-02-23","current":-2.275464,"twenty":-10.006862,"median":-4.432024,"eighty":-2.486846,"marketCap":159552861},{"date":"2024-03-01","current":-2.287899,"twenty":-9.776643,"median":-4.271017,"eighty":-2.449544,"marketCap":160424735},{"date":"2024-03-08","current":-2.001911,"twenty":-9.745947,"median":-4.196573,"eighty":-2.424675,"marketCap":140371643},{"date":"2024-03-15","current":-1.970826,"twenty":-9.744092,"median":-4.127323,"eighty":-2.35007,"marketCap":138191959},{"date":"2024-03-22","current":-1.796746,"twenty":-9.744092,"median":-3.981897,"eighty":-2.287899,"marketCap":125985729},{"date":"2024-03-28","current":-1.675569,"twenty":-9.733298,"median":-3.573319,"eighty":-2.275464,"marketCap":101137332},{"date":"2024-04-05","current":-2.094461,"twenty":-9.709993,"median":-3.420969,"eighty":-2.199615,"marketCap":126421666},{"date":"2024-04-12","current":-2.072794,"twenty":-9.700891,"median":-3.379418,"eighty":-2.090128,"marketCap":125113855},{"date":"2024-04-19","current":-2.665021,"twenty":-9.687625,"median":-3.254768,"eighty":-2.111795,"marketCap":160860671},{"date":"2024-04-26","current":-3.737907,"twenty":-9.574049,"median":-3.270203,"eighty":-2.116128,"marketCap":225620043},{"date":"2024-05-03","current":-4.502009,"twenty":-9.49731,"median":-3.407119,"eighty":-2.159044,"marketCap":271741268},{"date":"2024-05-10","current":-4.89959,"twenty":-8.765356,"median":-3.41781,"eighty":-2.190413,"marketCap":286699503},{"date":"2024-05-17","current":-6.390769,"twenty":-8.555367,"median":-3.573319,"eighty":-2.204775,"marketCap":373955874},{"date":"2024-05-24","current":-6.007323,"twenty":-8.382261,"median":-3.737907,"eighty":-2.231945,"marketCap":351518521},{"date":"2024-05-31","current":-5.591923,"twenty":-8.236161,"median":-3.981897,"eighty":-2.251609,"marketCap":327211389},{"date":"2024-06-07","current":-4.271164,"twenty":-8.139176,"median":-4.127323,"eighty":-2.264907,"marketCap":249927175},{"date":"2024-06-14","current":-4.015533,"twenty":-8.029209,"median":-4.079441,"eighty":-2.268667,"marketCap":234968940},{"date":"2024-06-21","current":-3.642739,"twenty":-7.95672,"median":-4.015533,"eighty":-2.271734,"marketCap":213154848},{"date":"2024-06-28","current":-3.727949,"twenty":-7.921709,"median":-3.977412,"eighty":-2.275464,"marketCap":218140926},{"date":"2024-07-05","current":-3.727949,"twenty":-7.889994,"median":-3.928937,"eighty":-2.276707,"marketCap":218140926},{"date":"2024-07-12","current":-4.041687,"twenty":-7.867543,"median":-3.951626,"eighty":-2.282925,"marketCap":236499340},{"date":"2024-07-19","current":-3.802019,"twenty":-7.818824,"median":-3.919672,"eighty":-2.287899,"marketCap":222475120},{"date":"2024-07-26","current":-4.23778,"twenty":-7.671633,"median":-3.972928,"eighty":-2.290386,"marketCap":247973702},{"date":"2024-08-02","current":-3.965429,"twenty":-7.563313,"median":-3.977412,"eighty":-2.30282,"marketCap":232037088},{"date":"2024-08-09","current":-3.693078,"twenty":-7.450529,"median":-3.972928,"eighty":-2.317741,"marketCap":216100475},{"date":"2024-08-16","current":-6.331005,"twenty":-7.327952,"median":-3.982738,"eighty":-2.340122,"marketCap":220439248},{"date":"2024-08-23","current":-6.480637,"twenty":-7.204873,"median":-4.015533,"eighty":-2.355044,"marketCap":225649304},{"date":"2024-08-30","current":-7.497208,"twenty":-7.492856,"median":-4.025346,"eighty":-2.376181,"marketCap":261045273},{"date":"2024-09-06","current":-6.630361,"twenty":-7.475447,"median":-4.052581,"eighty":-2.381155,"marketCap":230862542},{"date":"2024-09-13","current":-6.776887,"twenty":-7.472893,"median":-4.085772,"eighty":-2.387372,"marketCap":235964443},{"date":"2024-09-20","current":-8.132265,"twenty":-7.497208,"median":-4.101605,"eighty":-2.390574,"marketCap":283157332},{"date":"2024-09-27","current":-7.454576,"twenty":-7.497208,"median":-4.139734,"eighty":-2.424675,"marketCap":259560888},{"date":"2024-10-04","current":-8.022369,"twenty":-7.564472,"median":-4.172629,"eighty":-2.426686,"marketCap":279330882},{"date":"2024-10-11","current":-7.43626,"twenty":-7.58528,"median":-4.207257,"eighty":-2.437109,"marketCap":258923146},{"date":"2024-10-18","current":-9.011429,"twenty":-7.619419,"median":-4.255435,"eighty":-2.443326,"marketCap":313768936},{"date":"2024-10-25","current":-8.681742,"twenty":-7.710999,"median":-4.283136,"eighty":-2.443326,"marketCap":302289584},{"date":"2024-11-01","current":-8.022369,"twenty":-7.871872,"median":-4.341273,"eighty":-2.449544,"marketCap":279330882},{"date":"2024-11-08","current":-6.328847,"twenty":-7.875842,"median":-4.409078,"eighty":-2.461978,"marketCap":299044367},{"date":"2024-11-15","current":-4.366628,"twenty":-7.871872,"median":-4.447456,"eighty":-2.468195,"marketCap":206327554},{"date":"2024-11-22","current":-3.772435,"twenty":-7.850225,"median":-4.409078,"eighty":-2.474412,"marketCap":178251336},{"date":"2024-11-29","current":-4.214625,"twenty":-7.812108,"median":-4.379403,"eighty":-2.484359,"marketCap":199145266},{"date":"2024-12-06","current":-3.979712,"twenty":-7.747073,"median":-4.327977,"eighty":-2.486846,"marketCap":188045366},{"date":"2024-12-13","current":-3.150605,"twenty":-7.715439,"median":-4.283136,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-20","current":-3.150605,"twenty":-7.696777,"median":-4.255435,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-27","current":-3.454611,"twenty":-7.692898,"median":-4.233112,"eighty":-2.486846,"marketCap":163233825},{"date":"2025-01-03","current":-3.565159,"twenty":-7.679844,"median":-4.210941,"eighty":-2.489333,"marketCap":168457307},{"date":"2025-01-10","current":-2.984784,"twenty":-7.652352,"median":-4.189941,"eighty":-2.494306,"marketCap":141034024},{"date":"2025-01-17","current":-2.445865,"twenty":-7.615756,"median":-4.161948,"eighty":-2.488469,"marketCap":115569548},{"date":"2025-01-24","current":-2.376772,"twenty":-7.601103,"median":-4.145533,"eighty":-2.486846,"marketCap":112304871},{"date":"2025-01-31","current":-2.597867,"twenty":-7.587973,"median":-4.117946,"eighty":-2.474412,"marketCap":122751836},{"date":"2025-02-07","current":-2.293862,"twenty":-7.58528,"median":-4.092697,"eighty":-2.461978,"marketCap":108387259},{"date":"2025-02-14","current":-2.141859,"twenty":-7.564472,"median":-4.071459,"eighty":-2.445865,"marketCap":101204971},{"date":"2025-02-21","current":-1.934582,"twenty":-7.535166,"median":-4.045246,"eighty":-2.436096,"marketCap":91410942},{"date":"2025-02-28","current":-1.879308,"twenty":-7.503334,"median":-4.019899,"eighty":-2.390588,"marketCap":88799200},{"date":"2025-03-07","current":-1.741124,"twenty":-7.479799,"median":-4.012269,"eighty":-2.376772,"marketCap":82269847},{"date":"2025-03-14","current":-1.768761,"twenty":-7.473404,"median":-3.98358,"eighty":-2.360377,"marketCap":83575718},{"date":"2025-03-21","current":-1.920764,"twenty":-7.458239,"median":-3.97632,"eighty":-2.299039,"marketCap":90758006},{"date":"2025-03-28","current":-1.650561,"twenty":-7.439923,"median":-3.965429,"eighty":-2.286655,"marketCap":86494372},{"date":"2025-04-04","current":-1.343935,"twenty":-7.43626,"median":-3.888445,"eighty":-2.268957,"marketCap":70426247},{"date":"2025-04-11","current":-1.578798,"twenty":-7.43626,"median":-3.869164,"eighty":-2.22123,"marketCap":82733747},{"date":"2025-04-17","current":-1.604894,"twenty":-7.385018,"median":-3.866416,"eighty":-2.158607,"marketCap":84101247},{"date":"2025-04-25","current":-1.787565,"twenty":-7.336161,"median":-3.851042,"eighty":-2.091311,"marketCap":93673747},{"date":"2025-05-02","current":-1.918044,"twenty":-7.319952,"median":-3.834462,"eighty":-2.07178,"marketCap":100511247},{"date":"2025-05-09","current":-1.205655,"twenty":-7.300111,"median":-3.807466,"eighty":-2.049161,"marketCap":74868747},{"date":"2025-05-16","current":-1.106014,"twenty":-7.278743,"median":-3.786254,"eighty":-2.016502,"marketCap":68681247},{"date":"2025-05-23","current":-1.036265,"twenty":-7.271417,"median":-3.738253,"eighty":-2.007994,"marketCap":64349997},{"date":"2025-05-30","current":-1.016337,"twenty":-7.257385,"median":-3.729465,"eighty":-1.994142,"marketCap":63112497},{"date":"2025-06-06","current":-1.14587,"twenty":-7.235716,"median":-3.693078,"eighty":-1.973826,"marketCap":71156247},{"date":"2025-06-13","current":-1.215619,"twenty":-7.20548,"median":-3.669367,"eighty":-1.948401,"marketCap":75487497},{"date":"2025-06-20","current":-1.106014,"twenty":-7.150532,"median":-3.621436,"eighty":-1.94414,"marketCap":68681247},{"date":"2025-06-27","current":-1.14587,"twenty":-7.101064,"median":-3.600133,"eighty":-1.923316,"marketCap":71156247},{"date":"2025-07-03","current":-1.125942,"twenty":-7.079022,"median":-3.589482,"eighty":-1.914872,"marketCap":69918747},{"date":"2025-07-11","current":-1.385008,"twenty":-7.069942,"median":-3.569239,"eighty":-1.8789,"marketCap":86006247},{"date":"2025-07-18","current":-1.952961,"twenty":-7.051626,"median":-3.482969,"eighty":-1.86549,"marketCap":121274996},{"date":"2025-07-25","current":-1.673967,"twenty":-6.948723,"median":-3.46152,"eighty":-1.837853,"marketCap":103949996},{"date":"2025-08-01","current":-1.394972,"twenty":-6.9051,"median":-3.454611,"eighty":-1.787565,"marketCap":86624997}],"updateTime":1754242085968}}}